Holen Sie sich die Stockscreener-App
30.22
0.60%
0.18
Handel nachbörslich:
30.58
0.36
+1.19%
Veracyte Inc Aktie (VCYT) Neueste Nachrichten
Veracyte Inc. Builds Base for Possible ReboundPortfolio Return Report & Risk Adjusted Buy/Sell Alerts - newsyoung.net
Here's Why Veracyte (VCYT) is a Strong Growth Stock - au.finance.yahoo.com
Shareholders Can Be Confident That Veracyte's (NASDAQ:VCYT) Earnings Are High Quality - Yahoo Finance
Veracyte Inc. Inches Above Key Support — Safe to HoldJuly 2025 Institutional & Free Real-Time Volume Trigger Notifications - thegnnews.com
VCYT Stock Gains on Q2 Earnings and Revenue Beat, Margins Up - TradingView
Candlestick Signal Suggests Reversal in Veracyte Inc.Chart-Based Trade Entries Gain Analyst Support - metal.it
Veracyte stock price target lowered to $28 from $29 at Morgan Stanley - Investing.com Nigeria
Cautious Outlook on Veracyte: Sell Rating Amid Market Uncertainties and Valuation Concerns - TipRanks
Veracyte price target lowered to $28 from $29 at Morgan Stanley - TipRanks
A Quick Look at Today's Ratings for Veracyte(VCYT.US), With a Forecast Between $41 to $45 - 富途牛牛
Veracyte, Inc. (NASDAQ:VCYT) Q2 2025 Earnings Call Transcript - Insider Monkey
Decoding Veracyte Inc (VCYT): A Strategic SWOT Insight - GuruFocus
Veracyte Inc’s Earnings Call Highlights Robust Growth and Strategic Milestones - TipRanks
Veracyte Receives Buy Rating and $37 Price Target from Guggenheim Analyst - AInvest
Veracyte’s Strong Financial Performance and Promising Growth Prospects Justify Buy Rating - TipRanks
Helix and Veracyte Partner to Expand Access to Clinically Actionable Genomic Insights in Prostate Cancer Care - AInvest
Veracyte (VCYT) Q2 Revenue Jumps 14% - AOL.com
Veracyte stock rating reiterated at Outperform by William Blair - Investing.com India
Earnings call transcript: Veracyte’s Q2 2025 earnings beat expectations, stock falls - Investing.com Canada
Earnings call transcript: Veracyte’s Q2 2025 earnings beat expectations, stock falls By Investing.com - Investing.com South Africa
Veracyte's 2025 Earnings Call: A Catalyst-Driven Path to Sustained Double-Digit Growth and 25%+ Adjusted EBITDA Margins - AInvest
Veracyte: Q2 Earnings Snapshot - Greenwich Time
Veracyte's 2025 Q2 Financial Performance and Strategic Momentum: A Deep Dive into Diagnostic Innovation and Oncology Expansion - AInvest
Veracyte Announces Second Quarter 2025 Financial Results - BioSpace
Veracyte Reports Strong Q2 2025 Revenue Growth - TipRanks
Veracyte’s Revenue Growth Outpaces Forecasts And Lifts Guidance - Finimize
Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
Veracyte Q2 2025 slides: Decipher drives 14% revenue growth, EBITDA margins expand - Investing.com Nigeria
Veracyte Q2 revenue rises 14%, beats expectations - MarketScreener
Veracyte Inc (VCYT) Q2 2025 Earnings: Revenue Surpasses Estimates at $130.2M, Reports GAAP Net Loss - GuruFocus
Veracyte shares surge as Q2 profits quadruple expectations By Investing.com - Investing.com Nigeria
Veracyte Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Veracyte shares surge as Q2 profits quadruple expectations - Investing.com
Veracyte Inc earnings beat by $0.33, revenue topped estimates - Investing.com Canada
Veracyte reports Q2 EPS 44c, consensus 30c - TipRanks
Veracyte sees FY25 revenue $477M-$483M, consensus $491.92M - TipRanks
Earnings Flash (VCYT) Veracyte, Inc. Reports Q2 Revenue $130.2M, vs. FactSet Est of $121.0M - MarketScreener
Earnings Flash (VCYT) Veracyte, Inc. Posts Q2 Adjusted EPS $0.44 per Share, vs. FactSet Est of $0.26 - MarketScreener
Veracyte Q2 2025 Earnings Call Transcript - MarketBeat
Veracyte Inc (VCYT) Q2 2025 Earnings Report Preview: What to Look For - Yahoo Finance
What catalysts could drive Veracyte Inc. stock higher in 2025Invest smarter with daily market updates - Jammu Links News
How does Veracyte Inc. compare to its industry peersFree Stock Market Trend Analysis - Jammu Links News
How does Veracyte Inc. generate profit in a changing economyMaximize portfolio growth with strategic plans - Jammu Links News
How many analysts rate Veracyte Inc. as a “Buy”Invest confidently with professional market insights - Jammu Links News
Should I hold or sell Veracyte Inc. stock in 2025Achieve consistent double-digit growth rates - Jammu Links News
What is the risk reward ratio of investing in Veracyte Inc. stockUnlock exclusive investment alerts - Jammu Links News
How strong is Veracyte Inc. company’s balance sheetOutstanding capital appreciation - Jammu Links News
0.67%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):